Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Simard

Showing results (51-60 of 290) with videos related to

Pageof 29
Sort By:
Bioinformatics (Oxford, England)|April 29, 2017
VEXOR: an integrative environment for prioritization of functional variants in fine-mapping analysisAudrey Lemaçon, Charles Joly Beauparlant, Penny Soucy, et al.
European Journal of Human Genetics : EJHG|November 22, 2012
A focus group study on breast cancer risk presentation: one format does not fit allMichel Dorval, Karine Bouchard, Jocelyne Chiquette, et al.
Journal of Genetic Counseling|May 16, 2008
Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control populationMichel Dorval, Karine Bouchard, Elizabeth Maunsell, et al.
Endocrine Reviews|May 4, 2005
Gonadotropin-releasing hormone agonists in the treatment of prostate cancerFernand Labrie, Alain Bélanger, Van Luu-The, et al.
Trends in Cancer|November 3, 2020
PALB2 Variants: Protein Domains and Cancer SusceptibilityThales C Nepomuceno, Marcelo A Carvalho, Amélie Rodrigue, et al.
Medecine Sciences : M/S|November 13, 2003
[From the gene to the clinic: prostate cancer death can now be an exception?]Fernand Labrie, Leonello Cusan, José Luis Gomez, et al.
European Journal of Human Genetics : EJHG|January 24, 2013
Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talkKelly A McClellan, Erika Kleiderman, Lee Black, et al.
Oncotarget|November 8, 2017
Transcriptional signature of lymphoblastoid cell lines of <i>BRCA1</i>, <i>BRCA2</i> and non-<i>BRCA1/2</i> high risk breast cancer familiesMarie-Christine Pouliot, Charu Kothari, Charles Joly-Beauparlant, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 6, 2015
Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigationSylvie Pelletier, Nora Wong, Zaki El Haffaf, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 23, 2009
Analysis of 17beta-hydroxysteroid dehydrogenase types 5, 7, and 12 genetic sequence variants in breast cancer cases from French Canadian Families with high risk of breast and ovarian cancerMarie Plourde, Alexandra Ferland, Penny Soucy, et al.
Pageof 29

Showing results (51-60 of 290) with videos related to

Sort By:
Pageof 29
Bioinformatics (Oxford, England)|April 29, 2017
VEXOR: an integrative environment for prioritization of functional variants in fine-mapping analysisAudrey Lemaçon, Charles Joly Beauparlant, Penny Soucy, et al.
European Journal of Human Genetics : EJHG|November 22, 2012
A focus group study on breast cancer risk presentation: one format does not fit allMichel Dorval, Karine Bouchard, Jocelyne Chiquette, et al.
Journal of Genetic Counseling|May 16, 2008
Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control populationMichel Dorval, Karine Bouchard, Elizabeth Maunsell, et al.
Endocrine Reviews|May 4, 2005
Gonadotropin-releasing hormone agonists in the treatment of prostate cancerFernand Labrie, Alain Bélanger, Van Luu-The, et al.
Trends in Cancer|November 3, 2020
PALB2 Variants: Protein Domains and Cancer SusceptibilityThales C Nepomuceno, Marcelo A Carvalho, Amélie Rodrigue, et al.
Medecine Sciences : M/S|November 13, 2003
[From the gene to the clinic: prostate cancer death can now be an exception?]Fernand Labrie, Leonello Cusan, José Luis Gomez, et al.
European Journal of Human Genetics : EJHG|January 24, 2013
Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talkKelly A McClellan, Erika Kleiderman, Lee Black, et al.
Oncotarget|November 8, 2017
Transcriptional signature of lymphoblastoid cell lines of <i>BRCA1</i>, <i>BRCA2</i> and non-<i>BRCA1/2</i> high risk breast cancer familiesMarie-Christine Pouliot, Charu Kothari, Charles Joly-Beauparlant, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 6, 2015
Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigationSylvie Pelletier, Nora Wong, Zaki El Haffaf, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 23, 2009
Analysis of 17beta-hydroxysteroid dehydrogenase types 5, 7, and 12 genetic sequence variants in breast cancer cases from French Canadian Families with high risk of breast and ovarian cancerMarie Plourde, Alexandra Ferland, Penny Soucy, et al.
Pageof 29